MCEMP1
gene geneOn this page
Also known as MGC132456
Summary
MCEMP1 (mast cell expressed membrane protein 1, HGNC:27291) is a protein-coding gene on chromosome 19p13.2, encoding Mast cell-expressed membrane protein 1 (Q8IX19).
This gene encodes a single-pass transmembrane protein. Based on its expression pattern, it is speculated to be involved in regulating mast cell differentiation or immune responses.
Source: NCBI Gene 199675 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 19 total
- MANE Select transcript:
NM_174918
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27291 |
| Approved symbol | MCEMP1 |
| Name | mast cell expressed membrane protein 1 |
| Location | 19p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC132456 |
| Ensembl gene | ENSG00000183019 |
| Ensembl biotype | protein_coding |
| OMIM | 609565 |
| Entrez | 199675 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 3 protein_coding, 1 retained_intron
ENST00000333598, ENST00000597445, ENST00000598851, ENST00000950369
RefSeq mRNA: 1 — MANE Select: NM_174918
NM_174918
CCDS: CCDS12183
Canonical transcript exons
ENST00000333598 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001307153 | 7678104 | 7678241 |
| ENSE00001321470 | 7679098 | 7679829 |
| ENSE00001327405 | 7677637 | 7677726 |
| ENSE00002991851 | 7677090 | 7677175 |
| ENSE00003579774 | 7678350 | 7678400 |
| ENSE00003583525 | 7678491 | 7678604 |
| ENSE00003609595 | 7678924 | 7678983 |
Expression profiles
Bgee: expression breadth ubiquitous, 159 present calls, max score 95.68.
FANTOM5 (CAGE): breadth broad, TPM avg 5.5440 / max 1302.0576, expressed in 201 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 173591 | 2.5733 | 169 |
| 173593 | 1.3636 | 70 |
| 173592 | 0.9338 | 70 |
| 173595 | 0.3840 | 43 |
| 173590 | 0.1487 | 67 |
| 173594 | 0.1407 | 25 |
Top tissues by expression
249 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| monocyte | CL:0000576 | 95.68 | gold quality |
| leukocyte | CL:0000738 | 95.31 | gold quality |
| bone marrow | UBERON:0002371 | 94.96 | gold quality |
| right lung | UBERON:0002167 | 94.29 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 94.24 | gold quality |
| lower lobe of lung | UBERON:0008949 | 92.07 | gold quality |
| blood | UBERON:0000178 | 91.91 | gold quality |
| granulocyte | CL:0000094 | 91.26 | gold quality |
| visceral pleura | UBERON:0002401 | 90.82 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 90.06 | gold quality |
| bone marrow cell | CL:0002092 | 89.95 | gold quality |
| upper lobe of lung | UBERON:0008948 | 89.90 | gold quality |
| lung | UBERON:0002048 | 87.66 | gold quality |
| spleen | UBERON:0002106 | 87.20 | gold quality |
| pancreatic ductal cell | CL:0002079 | 86.20 | silver quality |
| vermiform appendix | UBERON:0001154 | 79.69 | gold quality |
| amniotic fluid | UBERON:0000173 | 78.09 | gold quality |
| bronchial epithelial cell | CL:0002328 | 71.65 | gold quality |
| caecum | UBERON:0001153 | 71.24 | gold quality |
| bronchus | UBERON:0002185 | 70.62 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 68.14 | gold quality |
| tibialis anterior | UBERON:0001385 | 67.34 | silver quality |
| adult organism | UBERON:0007023 | 67.34 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 67.15 | silver quality |
| omental fat pad | UBERON:0010414 | 64.94 | gold quality |
| peritoneum | UBERON:0002358 | 64.88 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 64.59 | gold quality |
| cartilage tissue | UBERON:0002418 | 64.29 | gold quality |
| left uterine tube | UBERON:0001303 | 63.58 | gold quality |
| medial globus pallidus | UBERON:0002477 | 63.37 | silver quality |
Single-cell (SCXA)
Detected in 7 experiment(s), a significant marker in 7.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-130148 | yes | 1978.73 |
| E-HCAD-15 | yes | 1353.31 |
| E-MTAB-6653 | yes | 1129.72 |
| E-CURD-122 | yes | 68.01 |
| E-CURD-112 | yes | 8.34 |
| E-MTAB-9801 | yes | 7.34 |
| E-ANND-3 | yes | 5.55 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
21 targeting MCEMP1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-3064-3P | 100.00 | 70.09 | 1254 |
| HSA-MIR-3941 | 99.86 | 70.54 | 2735 |
| HSA-MIR-623 | 99.76 | 68.16 | 1170 |
| HSA-MIR-4719 | 99.73 | 72.10 | 3329 |
| HSA-MIR-4446-5P | 99.72 | 69.19 | 2544 |
| HSA-MIR-4755-5P | 99.71 | 70.34 | 2716 |
| HSA-MIR-5006-3P | 99.71 | 70.26 | 2728 |
| HSA-MIR-4756-3P | 99.62 | 66.30 | 1319 |
| HSA-MIR-141-5P | 99.57 | 67.86 | 897 |
| HSA-MIR-3678-3P | 99.31 | 67.10 | 1432 |
| HSA-MIR-3692-5P | 99.29 | 67.04 | 1421 |
| HSA-MIR-642A-3P | 99.23 | 67.67 | 1258 |
| HSA-MIR-642B-3P | 99.23 | 67.67 | 1258 |
| HSA-MIR-4780 | 98.57 | 64.75 | 611 |
| HSA-MIR-1910-5P | 97.42 | 66.36 | 844 |
| HSA-MIR-3192-5P | 96.98 | 65.76 | 1926 |
| HSA-MIR-4474-3P | 96.97 | 65.87 | 870 |
| HSA-MIR-4524B-3P | 95.52 | 64.12 | 964 |
| HSA-MIR-1229-5P | 94.57 | 65.78 | 487 |
| HSA-MIR-5684 | 93.17 | 64.85 | 454 |
Literature-anchored findings (GeneRIF, showing 2)
- The expression of the gene MCEMP1 had the strongest association with stroke of 11,181 genes tested. (PMID:26846866)
- Mast-cell expressed membrane protein-1 is expressed in classical monocytes and alveolar macrophages in idiopathic pulmonary fibrosis and regulates cell chemotaxis, adhesion, and migration in a TGFbeta-dependent manner. (PMID:38189137)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Mcemp1 | ENSMUSG00000013974 |
| rattus_norvegicus | Mcemp1 | ENSRNOG00000028259 |
Protein
Protein identifiers
Mast cell-expressed membrane protein 1 — Q8IX19 (reviewed: Q8IX19)
All UniProt accessions (2): M0R0S5, Q8IX19
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Tissue specificity. Expressed specifically in mast cells. Found primarily in lung.
Miscellaneous. Alternative initiation is supported by proteomic data. Initiation from a downstream AUG is also supported by proteomic data.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8IX19-1 | 1 | yes |
| Q8IX19-2 | 2 |
RefSeq proteins (1): NP_777578* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR038818 | MCEMP1 | Family |
UniProt features (10 total): sequence variant 3, topological domain 2, chain 1, transmembrane region 1, region of interest 1, glycosylation site 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IX19-F1 | 75.43 | 0.53 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (1): 124
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-6798695 | Neutrophil degranulation |
| R-HSA-168249 | Innate Immune System |
| R-HSA-168256 | Immune System |
MSigDB gene sets: 91 (showing top):
REACTOME_INNATE_IMMUNE_SYSTEM, GOCC_SECRETORY_GRANULE, CEBPB_01, BROWN_MYELOID_CELL_DEVELOPMENT_UP, GOCC_SECRETORY_VESICLE, GOCC_SPECIFIC_GRANULE, GOCC_SECRETORY_GRANULE_MEMBRANE, chr19p13, KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP, MARTENS_TRETINOIN_RESPONSE_UP, WIERENGA_STAT5A_TARGETS_DN, GOCC_SPECIFIC_GRANULE_MEMBRANE, GOCC_TERTIARY_GRANULE, GOCC_TERTIARY_GRANULE_MEMBRANE, REACTOME_NEUTROPHIL_DEGRANULATION
GO Biological Process (0):
GO Molecular Function (2): identical protein binding (GO:0042802), protein binding (GO:0005515)
GO Cellular Component (4): plasma membrane (GO:0005886), specific granule membrane (GO:0035579), tertiary granule membrane (GO:0070821), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Innate Immune System | 1 |
| Immune System | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| secretory granule membrane | 2 |
| protein binding | 1 |
| binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| specific granule | 1 |
| tertiary granule | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
734 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MCEMP1 | CLEC12A | Q5QGZ9 | 506 |
| MCEMP1 | SIRPA | P78324 | 466 |
| MCEMP1 | CEACAM1 | P13688 | 464 |
| MCEMP1 | NFKB1 | P19838 | 447 |
| MCEMP1 | PET100 | P0DJ07 | 444 |
| MCEMP1 | PCP2 | Q8IVA1 | 442 |
| MCEMP1 | PPM1N | Q8N819 | 432 |
| MCEMP1 | CD93 | Q9NPY3 | 427 |
| MCEMP1 | OLR1 | P78380 | 427 |
| MCEMP1 | PTPRB | P23467 | 405 |
| MCEMP1 | CD59 | P13987 | 403 |
| MCEMP1 | CLEC4D | Q8WXI8 | 401 |
| MCEMP1 | SCARB2 | Q14108 | 400 |
| MCEMP1 | CD36 | P16671 | 399 |
| MCEMP1 | SCARB1 | Q8WTV0 | 397 |
IntAct
42 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MCEMP1 | JOSD2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRAF2 | MCEMP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ATP6V0C | MCEMP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CNIH1 | MCEMP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MALL | MCEMP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MCEMP1 | MCEMP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MCEMP1 | ZDHHC15 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MCEMP1 | CMTM5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ASGR2 | MCEMP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DGAT2L6 | MCEMP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ASGR1 | MCEMP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ARL6IP1 | MCEMP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MCEMP1 | GUK1 | psi-mi:“MI:0914”(association) | 0.350 |
| PRAF2 | MCEMP1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| MCEMP1 | MCEMP1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ATP6V0C | MCEMP1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CNIH1 | MCEMP1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| MALL | MCEMP1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZDHHC15 | MCEMP1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ASGR1 | MCEMP1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CMTM5 | MCEMP1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| MCEMP1 | ASGR2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| DGAT2L6 | MCEMP1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ARL6IP1 | MCEMP1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (16): JOSD2 (Affinity Capture-MS), JOSD2 (Affinity Capture-MS), MCEMP1 (Two-hybrid), MCEMP1 (Two-hybrid), MCEMP1 (Two-hybrid), MCEMP1 (Two-hybrid), MCEMP1 (Two-hybrid), MCEMP1 (Two-hybrid), MCEMP1 (Two-hybrid), MCEMP1 (Two-hybrid), DGAT2L6 (Two-hybrid), ATP6V0C (Two-hybrid), PRAF2 (Two-hybrid), MCEMP1 (Affinity Capture-RNA), GUK1 (Affinity Capture-MS)
ESM2 similar proteins: A4KWA1, D4AD02, O70156, O70215, O95971, P08290, P21854, P21855, P22272, P22273, P24721, P25118, P27471, P27811, P27812, P27814, P34902, P49300, P49301, Q01114, Q0VCS6, Q149M0, Q2HXU8, Q2NL33, Q3B8P2, Q566E6, Q5NKN2, Q5QGZ9, Q60513, Q60660, Q6QLQ4, Q6SJQ7, Q6UXB4, Q6UXN8, Q8BNX1, Q8BRU4, Q8BWY2, Q8C1T8, Q8IUN9, Q8IX19
Diamond homologs: Q8IX19, Q9D8U6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
19 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 12 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
925 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:7677112:G:GT | donor_gain | 1.0000 |
| 19:7677142:G:T | donor_gain | 1.0000 |
| 19:7677154:G:GT | donor_gain | 1.0000 |
| 19:7678102:A:AG | acceptor_gain | 1.0000 |
| 19:7678103:G:GA | acceptor_gain | 1.0000 |
| 19:7678237:GAAGA:G | donor_gain | 1.0000 |
| 19:7678239:AGAG:A | donor_loss | 1.0000 |
| 19:7678240:GA:G | donor_gain | 1.0000 |
| 19:7678242:G:C | donor_loss | 1.0000 |
| 19:7678242:G:GG | donor_gain | 1.0000 |
| 19:7678313:T:TA | acceptor_gain | 1.0000 |
| 19:7678314:G:A | acceptor_gain | 1.0000 |
| 19:7678922:AGG:A | acceptor_loss | 1.0000 |
| 19:7677727:G:GC | donor_loss | 0.9900 |
| 19:7677728:T:A | donor_loss | 0.9900 |
| 19:7678096:T:TA | acceptor_gain | 0.9900 |
| 19:7678103:G:GT | acceptor_loss | 0.9900 |
| 19:7678103:GT:G | acceptor_gain | 0.9900 |
| 19:7678103:GTC:G | acceptor_gain | 0.9900 |
| 19:7678103:GTCC:G | acceptor_gain | 0.9900 |
| 19:7678103:GTCCC:G | acceptor_gain | 0.9900 |
| 19:7678239:AGA:A | donor_gain | 0.9900 |
| 19:7678240:GAG:G | donor_gain | 0.9900 |
| 19:7678244:GAGTA:G | donor_loss | 0.9900 |
| 19:7678245:AGT:A | donor_loss | 0.9900 |
| 19:7678246:G:GG | donor_gain | 0.9900 |
| 19:7678387:G:GT | donor_gain | 0.9900 |
| 19:7678489:A:AG | acceptor_gain | 0.9900 |
| 19:7678490:G:GG | acceptor_gain | 0.9900 |
| 19:7678614:T:TA | donor_gain | 0.9900 |
AlphaMissense
1230 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:7678172:A:C | S85R | 0.937 |
| 19:7678174:C:A | S85R | 0.937 |
| 19:7678174:C:G | S85R | 0.937 |
| 19:7678208:T:C | C97R | 0.936 |
| 19:7678392:T:C | L122P | 0.914 |
| 19:7678383:A:T | K119I | 0.911 |
| 19:7677662:T:A | N40K | 0.903 |
| 19:7677662:T:G | N40K | 0.903 |
| 19:7678371:T:C | L115P | 0.886 |
| 19:7677675:T:C | F45L | 0.885 |
| 19:7677677:C:A | F45L | 0.885 |
| 19:7677677:C:G | F45L | 0.885 |
| 19:7678493:T:C | S126P | 0.873 |
| 19:7677664:T:C | I41T | 0.871 |
| 19:7678384:A:C | K119N | 0.839 |
| 19:7678384:A:T | K119N | 0.839 |
| 19:7677664:T:G | I41S | 0.834 |
| 19:7677654:T:C | Y38H | 0.829 |
| 19:7677661:A:T | N40I | 0.822 |
| 19:7677659:G:C | E39D | 0.814 |
| 19:7677659:G:T | E39D | 0.814 |
| 19:7678240:G:C | K107N | 0.800 |
| 19:7678240:G:T | K107N | 0.800 |
| 19:7677661:A:C | N40T | 0.793 |
| 19:7678199:T:C | F94L | 0.784 |
| 19:7678201:T:A | F94L | 0.784 |
| 19:7678201:T:G | F94L | 0.784 |
| 19:7678499:T:C | S128P | 0.782 |
| 19:7678969:T:C | L178P | 0.777 |
| 19:7678224:C:A | A102D | 0.776 |
dbSNP variants (sampled 300 via entrez): RS1000274168 (19:7675653 C>T), RS1000646037 (19:7675210 G>A), RS1001094088 (19:7679301 CGTGT>C,CGT), RS1001908911 (19:7676597 C>A,G,T), RS1001967496 (19:7679156 T>C), RS1002194581 (19:7676303 T>G), RS1002579530 (19:7678903 C>A,G,T), RS1002794302 (19:7675126 T>A), RS1002969179 (19:7680321 C>T), RS1003001701 (19:7680079 G>A,T), RS1003464243 (19:7677541 C>G), RS1003872861 (19:7676310 C>T), RS1004213947 (19:7676542 G>A), RS1005764157 (19:7678908 C>G,T), RS1006093725 (19:7676248 C>T)
Disease associations
OMIM: gene MIM:609565 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| alpha phellandrene | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| cobaltous chloride | increases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects cotreatment, decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| Pioglitazone | increases expression | 1 |
| Allergens | decreases expression | 1 |
| Benzene | increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cisplatin | increases expression | 1 |
| Iron | increases expression | 1 |
| Lipopolysaccharides | decreases expression, affects cotreatment | 1 |
| Tetrachlorodibenzodioxin | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Tretinoin | increases expression | 1 |
| Vitamin D | affects expression | 1 |
| Aflatoxin B1 | increases expression | 1 |
| Antirheumatic Agents | decreases expression | 1 |
| beta-Naphthoflavone | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.